Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
RC-402 by Virocure for Cutaneous Squamous Cell Carcinoma (cSCC): Likelihood of Approval
RC-402 is under clinical development by Virocure and currently in Phase I for Cutaneous Squamous Cell Carcinoma (cSCC). According to...
Data Insights
RC-402 by Virocure for Metastatic Colorectal Cancer: Likelihood of Approval
RC-402 is under clinical development by Virocure and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...